Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study

Authors: Andrew Menzies‐Gow, Mark Gurnell, Liam G. Heaney, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Timothy Harrison, David J. Jackson, David Price, Njira Lugogo, James L. Kreindler, Annie Burden, Alex De Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther García Gil - The Lancet 2021 cited by 174